Delivery Order SPE2DB25D3306-SPE2DB25FUBVZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,590.84 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL) on December 8, 2025, with an ultimate completion date of December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $2,372.92 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on June 18, 2025, with an ultimate completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL units) at a ceiling value of $1,883.10. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of November 26, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a $1,803.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for NovoLog 100 Unit/mL vials (10 mL units). This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $1,255.40. This non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) under a firm fixed-price contract with a ceiling value of $2,983.84. This non-set-aside delivery order is scheduled for completion by October 30, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,015.50 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on June 16, 2025, with an ultimate completion date of June 17, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,436.08 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The pharmaceutical product will support federal medical supply chain requirements,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL) with a ceiling value of $1,619.42. This firm fixed-price delivery order is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a contract value of $1,335.25. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award to the prime contractor. The order is scheduled for completion by December 17, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUBVZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL units) with a ceiling value of $1,296.60. This is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor headquartered in Pennsylvania that serves federal medical procurement needs for military and veteran healthcare systems, consistently demonstrating capability to fulfill federal requirements through its extensive portfolio of drug and medical supply deliveries across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/30/25 |